The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Glycine

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Glycine.
Olatoyosi Odenike
Connection Strength
0.182
Glycine
  1. Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study. Blood. 2021 04 01; 137(13):1792-1803.
    View in: PubMed
    Score: 0.182
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.